Startups
Next generation full-body embolicprotection for TAVI The European Commission Horizon 2020 Program Backs Filterlex’sEmbolic Protection Device – CAPTIS €2.1M Grant to support Filterlex’s CAPTIS clinical trials READ MORE FILTERLEX Our goal is to develop the next generation embolic protection device to reduce the risk of stroke and other complications during catheter-based structural heart procedures. The … Filterlex Read More »
Overview
Employees
11-50
Total raised
$9M
Founded date
2015
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 15, 2019 | Series A round | $3M |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 15, 2019 | Filterlex Medical Completes $3M Series A Financing | Sigal Eli and Giora Weisz of Filterlex Medical receives the Best Innovation Award at the EuroPCR 2019 for the CAPTIS Embolic Protection Device for TAVR Filterlex Medical, a Yokneam, Israel-based medical device startup, completed a series A ... |
Reviews 0
FAQ about Filterlex
When was Filterlex founded?
Filterlex was founded in 2015.
How much funding has Filterlex raised?
Filterlex has raised $9M in total across 2 funding rounds.
What funding rounds has Filterlex raised?
Parsers VC lists 2 funding rounds of Filterlex, among them a Series A round of $3M on Jul 15, 2019.
What has the press written about Filterlex?
Parsers VC has collected 2 articles mentioning Filterlex, among them “Filterlex Medical Completes $3M Series A Financing” (Jul 15, 2019).
Is Filterlex still active?
Yes, Filterlex is active; its latest activity on Parsers VC dates from Nov 19, 2021.